To explore the underlying mechanism of the observed synthetic lethality induced by GSK3β inhibition, we first compared the basal expression levels of GSK3β in FHIT-expressing and FHIT-mutant lung cancer cell lines. The gene discussed is GSK3B; the disease is lung cancer.